Laser Closure of Anal Fistula (FiLaC)
Launched by SURP PIRGIÇ ARMENIAN HOSPITAL · Nov 11, 2019
Trial Information
Current as of May 09, 2025
Unknown status
Keywords
ClinConnect Summary
Despite the developments in the surgical field, the treatment of anal fistula is still a challenging problem, especially in complex, transsphincteric cases. The surgical treatment aims to avoid recurrences and also to preserve normal sphincter functions. The FiLaC procedure was recently reported non-invasive technique in perianal fistulas for treatment and preserving anal sphincter function with a good success rate. In 2018, one of our colleagues published a 40% complete healing rate by using only FiLaC technique in 103 consecutive perianal fistula patients (Prof. Cem Terzi). Some authors a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • complex anal fistula
- • high anal fistulas
- • recurrent anal fistulas
- Exclusion Criteria:
- • superficial anal fistulas
- • multibranching anal fistulas
About Surp Pırgiç Armenian Hospital
Surp Pırgiç Armenian Hospital is a distinguished healthcare institution dedicated to providing high-quality medical services and advancing clinical research. Located in the heart of the community, the hospital is committed to enhancing patient care through innovative treatments and evidence-based practices. With a focus on multidisciplinary collaboration, Surp Pırgiç Armenian Hospital actively sponsors clinical trials aimed at exploring new therapeutic interventions and improving health outcomes. The hospital's research initiatives are guided by a commitment to ethical standards and patient safety, ensuring that all studies contribute valuable insights to the medical field while prioritizing the well-being of participants.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Zeytinburnu, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials